1. Home
  2. TLSA vs PED Comparison

TLSA vs PED Comparison

Compare TLSA & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

N/A

Current Price

$1.15

Market Cap

145.1M

Sector

Health Care

ML Signal

N/A

Logo Pedevco Corp.

PED

Pedevco Corp.

N/A

Current Price

$13.01

Market Cap

152.8M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
TLSA
PED
Founded
2013
N/A
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
145.1M
152.8M
IPO Year
2017
2012

Fundamental Metrics

Financial Performance
Metric
TLSA
PED
Price
$1.15
$13.01
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $7.97
N/A
AVG Volume (30 Days)
★ 545.0K
29.7K
Earning Date
05-01-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $45,751,000.00
Revenue This Year
N/A
$212.12
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 15.67
52 Week Low
$0.76
$0.43
52 Week High
$2.33
$18.89

Technical Indicators

Market Signals
Indicator
TLSA
PED
Relative Strength Index (RSI) 59.09 41.86
Support Level $0.90 $11.41
Resistance Level $1.20 $13.92
Average True Range (ATR) 0.09 1.05
MACD 0.02 -0.25
Stochastic Oscillator 94.69 1.85

Price Performance

Historical Comparison
TLSA
PED

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties with a long production history, well-defined geology, and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming, the Powder River Basin (PRB) in Wyoming, and the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin).

Share on Social Networks: